Purpose, audience, and the prescription firewall

This volume gives experts a falsifiable corrective direction for hundreds of rare diseases. It is not a prescription, diagnosis, treatment, or cure, and carries no dose. A safety firewall appears three times on every disease page, because a drug name beside a disease name is easily misread. The only proper next step is a controlled experiment.

This volume offers a single thing to a single audience: a falsifiable, mechanism-level corrective direction for each of hundreds of rare diseases, offered to researchers and clinicians for evaluation. It is not, and must not be read as, a prescription.

What this is

For 839 rare diseases, a bistable molecular switch (the R19 double-well) is emerged from the real promoter DNA of the lead gene, and the geometry of that switch is used to read off which way the switch must be pushed to move the cell from the diseased branch toward the healthy branch. That single output — a signed direction — is the load-bearing claim of every page. It is graded [F] forced (it follows necessarily from the cusp sign) and it is falsifiable (each lever ships with the experiment that would break it).

What this is not

It is not a diagnosis, a treatment, or a cure. It is a computer-simulation hypothesis.
It is not medical advice and not a prescription. No individual should act on it.
It carries no dose, no efficacy, no potency, and no safety magnitude — direction only [O].
It is not an approved method. No regulator has cleared anything described here.

The firewall, stated three times on every disease page

Because a list of drug names beside a disease name is so easily misread, every disease page carries the same safety notice three times, by design: a banner at the top, a banner directly beside the agent names, and a banner at the bottom that also explains why no dose is printed. A short inline notice rides on every individual candidate card as well. The repetition is deliberate redundancy, not an oversight.

✓ The honest reading. A disease page says, in effect: “the geometry says push this switch this way; here are agents whose known action happens to push the same way; a competent expert should now decide whether that is worth a controlled test.” Nothing more.

Who this is for

Disease biologists, translational researchers, and clinician-scientists who can design and run the controlled experiments that would confirm or refute a direction. The appropriate next step after any page is an experiment, never use in a person.